The debate over weight-loss drugs and beer sales is gaining more attention as GLP-1 medications such as Ozempic and Wegovy become widely used.
Heineken has warned British pubs and bars that these treatments could reduce alcohol purchases. However, the brewer also says users are not necessarily giving up alcohol.
Early spending data remain observational, while other brewers interpret the evidence differently, leaving the long-term impact on beer demand uncertain.
Heineken Weight-Loss Drugs Warning
Heineken’s presentation to UK hospitality customers identifies GLP-1 medications, including Ozempic and Wegovy, as a potential threat to beer and cider demand.
The drugs can suppress appetite and reduce the desire to drink, creating what the document describes as “fullness and fewer serves”, according to Reuters (23 October 2026).
The brewer recommends that pubs promote half-pints, smaller 280ml glasses, low- and no-alcohol options, and small food pairings. Heineken says users are not abandoning alcohol but favouring smaller servings, lower-strength drinks and premium products.
It describes the presentation as part of its regular engagement with UK operators and plans to monitor consumer behaviour through 2027.
The commercial context is significant. Heineken UK’s 2026 Beer Report values hospitality beer sales at nearly £14 billion, while low- and no-alcohol beer reached £271 million.
Weight Loss Drugs and Beer Sales: Purchase Data and Research So Far
Early evidence linking GLP-1 alcohol consumption to lower spending comes from US retail data. Circana figures cited by the Reuters report show that households with a GLP-1 medication user spent around 7% less on alcohol monthly after two years, including 13.5% less on beer, compared with households without a user.
Having said that, these observational figures cannot establish that medication caused the decline.
Clinical research offers further insight. A 2025 JAMA Psychiatry trial, involving 48 adults with alcohol use disorder, found that low-dose semaglutide reduced drinks per drinking occasion and alcohol cravings. It did not considerably reduce average daily consumption or drinking frequency.
Researchers called for larger trials before drawing firm conclusions.
Weight Loss Drugs and Beer Sales: Other Brewers and Drinks Companies Read It Differently
Not all major drinks companies share Heineken’s level of concern about weight-loss drugs and beer sales. Diageo has told investors that any impact from GLP-1 medication should remain manageable, even if usage increases.
Carlsberg, meanwhile, told Reuters that existing evidence does not yet identify these treatments as a clear driver of beer consumption trends. AB InBev declined to comment. However, market growth could increase the industry’s exposure.
JPMorgan research estimates that around 10 million Americans used these medications last year. In the UK, ING Think estimates that at least 2% of adults currently use GLP-1 drugs, highlighting the potential reach across European drinks markets.
Weight Loss Drugs and Beer Sales: Pint Sizes, Beer Styles and Pub Economics
The potential impact of weight-loss drugs and beer sales could encourage UK pubs to review portion sizes, pricing and product ranges. Half-pints and third-of-a-pint servings may appeal to customers looking to moderate alcohol consumption without avoiding pubs altogether.
But smaller measures could affect revenue and profit margins, depending on pricing, customer numbers and overall spending. Individual publicans will need to assess the commercial impact.
Beer styles also deserve attention. Heineken highlights lower-strength and premium beers as potential opportunities, alongside alcohol-free alternatives. However, its figures place low- and no-alcohol beer at around 2% of UK on-trade beer sales, showing that this category still has considerable room for growth.
US spending data and consumer surveys indicate changing drinking habits, but the long-term effect on UK pub sales remains uncertain. Heineken’s recommendations are clear, as causation, market scale and lasting demand changes are not yet established.
The Beer Post actively partners with producers, trade suppliers, and hospitality operators across the beer sector. Get in touch with The Beer Post to stay informed, connect with industry opportunities and reach international beer markets!